Identification of predictors of recurrence in patients with lower rectal cancer undergoing neoadjuvant chemotherapy: A direct comparison of short-course and long-course chemoradiotherapy

Akira Yamamoto, Yuji Toiyama, Yoshinaga Okugawa, Susumu Saigusa, Shozo Ide, Hiroyuki Fujikawa, Junichiro Hiro, Hiromi Yasuda, Shigeyuki Yoshiyama, Masaki Ohi, Toshimitsu Araki, Masato Kusunoki

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Objective: This study aimed to investigate clinicopathological responses and oncological outcome in patients receiving short- or long-course chemoradiotherapy (CRT) and to assess the predictive factor for recurrence in each treatment. Methods: A total of 118 rectal cancer patients receiving preoperative CRT were enrolled. Clinicopathological responses and oncological outcome in patients receiving short- or long-course CRT were investigated. Results: Despite there being no significant differences in the prognosis of disease-free survival (DFS) based on TNM stage classification in patients receiving long-course CRT, patients with advanced stage demonstrated poor DFS after short-course CRT. The presence of lymph node metastasis was a predictor of poor DFS in short-course CRT, whereas poor pathological response was a predictor of recurrence in long-course CRT. Conclusions: Distinct predictors of recurrence depending on the CRT course might be needed to discriminate candidates from rectal cancer patients receiving preoperative CRT who might benefit from more intensive adjuvant therapy after surgery.

Original languageEnglish
Pages (from-to)70-78
Number of pages9
JournalOncology (Switzerland)
Volume96
Issue number2
DOIs
Publication statusPublished - 01-02-2019
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Identification of predictors of recurrence in patients with lower rectal cancer undergoing neoadjuvant chemotherapy: A direct comparison of short-course and long-course chemoradiotherapy'. Together they form a unique fingerprint.

Cite this